{
  "type": "hyp",
  "text": "We observed in the present study that lysoPC (1 to 10 micromol/L) dose-dependently reduced TF activity in human monocytes as elicited by lipopolysaccharide (LPS).\n",
  "self": {
    "NER": {
      "answers": [
        "lysoPC",
        "1",
        "10",
        "TF",
        "LPS"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What drug reduced TF activity in human monocytes?",
          "What is the dose-dependent effect of lysoPC on TF activity?",
          "What is the dose of lysoPC?",
          "What activity was reduced by lysoPC?",
          "What is the name of the substance that causes TF activity to decrease?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "We",
        "the present study",
        "lysoPC",
        "(1 to 10 micromol/L",
        "dose",
        "TF activity",
        "human monocytes",
        "lipopolysaccharide",
        "(LPS"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What did the present study show about lysoPC?",
          "What study showed that lysoPC reduced TF activity in human monocytes?",
          "What drug reduced TF activity in human monocytes?",
          "What dose-dependently reduced TF activity in human monocytes?",
          "What was the main factor that elicited TF activity?",
          "What did lysoPC reduce in human monocytes?",
          "What did lysoPC reduce TF activity in?",
          "What is the name of the substance that causes TF activity to be reduced?",
          "What is the name of the lipopolysaccharide?"
        ]
      }
    }
  },
  "asked": {
    "What drug reduced TF activity in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lipopolysaccharide",
        "answerability": 0.9894471168518066,
        "ground_truth": {
          "lysoPC": {
            "bertscore": 0.7024450898170471,
            "f1": 0
          }
        }
      }
    },
    "What is the dose-dependent effect of lysoPC on TF activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "reduced",
        "answerability": 0.9999403953552246,
        "ground_truth": {
          "1": {
            "bertscore": 0.775714635848999,
            "f1": 0
          }
        }
      }
    },
    "What is the dose of lysoPC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "1 to 10 micromol/L",
        "answerability": 0.8788674473762512,
        "ground_truth": {
          "10": {
            "bertscore": 0.5923558473587036,
            "f1": 0.4
          }
        }
      }
    },
    "What activity was reduced by lysoPC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "TF",
        "answerability": 0.9910020232200623,
        "ground_truth": {
          "TF": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is the name of the substance that causes TF activity to decrease?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lipopolysaccharide",
        "answerability": 0.8333823680877686,
        "ground_truth": {
          "LPS": {
            "bertscore": 0.6216585636138916,
            "f1": 0
          }
        }
      }
    },
    "What did the present study show about lysoPC?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "dose-dependently reduced TF activity",
        "answerability": 0.9995902180671692,
        "ground_truth": {
          "We": {
            "bertscore": 0.5810472369194031,
            "f1": 0
          }
        }
      }
    },
    "What study showed that lysoPC reduced TF activity in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "present study",
        "answerability": 0.968199610710144,
        "ground_truth": {
          "the present study": {
            "bertscore": 0.8894290328025818,
            "f1": 1.0
          }
        }
      }
    },
    "What dose-dependently reduced TF activity in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lysoPC",
        "answerability": 0.9898273944854736,
        "ground_truth": {
          "(1 to 10 micromol/L": {
            "bertscore": 0.6004543900489807,
            "f1": 0
          }
        }
      }
    },
    "What was the main factor that elicited TF activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lipopolysaccharide",
        "answerability": 0.6383476853370667,
        "ground_truth": {
          "dose": {
            "bertscore": 0.5642300844192505,
            "f1": 0
          }
        }
      }
    },
    "What did lysoPC reduce in human monocytes?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "TF activity",
        "answerability": 0.9965965747833252,
        "ground_truth": {
          "TF activity": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What did lysoPC reduce TF activity in?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "human monocytes",
        "answerability": 0.9551059007644653,
        "ground_truth": {
          "human monocytes": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What is the name of the substance that causes TF activity to be reduced?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "lipopolysaccharide",
        "answerability": 0.8843833208084106,
        "ground_truth": {
          "lipopolysaccharide": {
            "bertscore": 0.9999999403953552,
            "f1": 1.0
          }
        }
      }
    },
    "What is the name of the lipopolysaccharide?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.01924365758895874,
        "ground_truth": {
          "(LPS": {
            "bertscore": 0.6541221737861633,
            "f1": 0
          }
        }
      }
    }
  }
}